The Welsh Gender Service surgical pause

NHS WALES · WELSH GENDER SERVICE

On 26 August 2026 the NHS Wales Joint Commissioning Committee stopped gender affirming surgery for Welsh patients. Referrals, surgical assessments and operations already scheduled were all paused. Cardiff and Vale counted 451 people who may be affected, as at 11 September. Some learned that their operation was cancelled hours before it was due, after they had been admitted. This page sets out our position; the pages beneath it collect everything we have published and everything we have asked.

Corrected, 10 October 2026: this paragraph previously said “Four hundred and fifty-one people are affected.” That is Cardiff and Vale’s count of 11 September, its wording is people who “may be impacted”, and no later figure has been published.

Our position, in short

The pause may have been necessary. If the commissioner holds a specific documented concern that individual referrals were made without adequate clinical assessment, then allowing irreversible surgery to proceed while that question was open would have been indefensible. We have never claimed otherwise, and nothing here asks for a service to continue unexamined.

The referral-rate concern is real and now published. Four hundred and three referrals from Wales in 2025-26 against a population of 3.19 million, against 1,803 from English services against 58.6 million. Roughly four times the rate. Clinicians and surgeons working in the English service raised concerns about some Welsh referrals. Those are facts, and anyone arguing this was manufactured has to account for them.

But the scope of the pause has never been justified in public. The Committee’s own Quality Impact Assessment records that 97% of patients listed for masculinising chest surgery proceed to surgery, against 36% of those listed for masculinising genital surgery; the terms of reference give 34% for the latter, over a differently described population. Of the 403 referrals, 201 were for chest surgery and 53 for masculinising genital surgery. The low-progression concern — one of the two limbs of the public case — belongs to the smallest of the three categories. Surgery was stopped for all three. At the meeting of 22 September the Chief Commissioner said a narrower option, limiting the pause to people awaiting assessment, and a wider one were considered, and that clinicians advised the decision taken. That advice has not been published.

Corrected, 10 October 2026: this previously said the scope “has never been justified”, without the Chief Commissioner’s account that options were considered, and gave the 53 as “genital surgery” rather than masculinising genital surgery. The terms of reference’s 34% is now given beside the 36%.

Most commitments made with a date concern documents. None of the commitments to give patients their surgery back carries a date.

Corrected, 10 October 2026: this previously read “Every commitment made with a date concerns a document. Every commitment made without one concerns a patient getting their surgery back.” Our own commitments tracker contradicted both halves: one dated commitment concerns reviewing patients, and some undated ones concern documents or contact.

The Committee’s own documents are more cautious than its public case. The Quality Impact Assessment describes the low progression figure as an outlier requiring further investigation, which should not at this stage be treated as proof that patients were referred inappropriately, and says the information should be treated as a signal requiring investigation rather than proof. The health board’s published answers say it is not known whether any patient was referred inappropriately, that no patient has been identified as having undergone surgery inappropriately, and that no immediate patient safety concerns have been identified.

The evidence has not been characterised. The complaints relied upon have been described four different ways, in three documents and at the meeting of 22 September: members of the public, some patients, families of people going through this, and information from clinicians and correspondence received. The Committee’s own Equality and Welsh Language Impact Assessment lists, as an action still to be taken, clarifying their source, nature and number and distinguishing affected patients from wider public or media concerns. That action remains outstanding.

Corrected, 10 October 2026: this previously said “across four documents”. One of the four descriptions, “families of people going through this”, was given at the meeting of 22 September and is on the recording rather than in a document.

Necessity and proportionality have not been assessed. The equality assessment lists reviewing the pause to ensure it remains necessary, objectively justified, proportionate and time-limited as work still to be done, and the Quality Impact Assessment says proportionality “should be kept under regular review”. That is the legal test for a measure of this kind, and it appears in the future tense. Both documents were created on 16 September, three weeks after the decision.

Corrected, 10 October 2026: this paragraph previously said both impact assessments list that action. Only the equality assessment does. The Quality Impact Assessment’s own wording is now quoted, and the same correction is made under “What we are asking for” below.

And the decision record has not been published. The Committee’s statement of 4 September says the Quality, Safety and Outcomes Committee considered the information and concluded that the service should be escalated and surgery paused. At the Joint Committee meeting on 22 September the Committee Secretary said that body is not a forum that made the decision, and that its role is to scrutinise and advise; the Chief Commissioner said “We took the decision”; the Welsh Government, in a freedom of information answer of 28 September, called the escalation and the pause “clinical decisions made by the NHS Wales Joint Commissioning Committee”; and a Joint Committee lay member said the matter had been scrutinised in a private (“in-committee”) session of that sub-committee. No decision paper has been published, no escalation letter to the provider has been mentioned, and no Executive Lead has been named. The Committee Secretary has said the minutes and the paper will be published, around 21 October.

Corrected, 6 October 2026: this paragraph previously opened “And nobody has said who decided.” That overstated the record. The Chief Commissioner’s words and the lay member’s, both spoken at the meeting of 22 September, were on the recording and we missed them. The paragraph has been reworded to include them. Our full reading is in The published record, analysed.

What we are asking for

Four things, none of them onerous, and none of which would delay the review.

The number and source of the complaints relied upon, distinguishing patients of the service from others. The Committee’s own document says this needs clarifying, and a count identifies nobody.

The decision record — which body decided, on what paper, on what date, with what advice.

An assessment of necessity and proportionality, published. The equality assessment lists it as outstanding, and the Quality Impact Assessment says proportionality should be kept under regular review.

And, now that the terms of reference are published, the three things they leave out: the review framework and the definitions of eligibility, readiness, appropriateness, adequate assessment and insufficient information, which the document provides for being agreed separately; the number and disciplines of the reviewers, with the arrangements for managing conflicts of interest; and the criteria that would bring the pause to an end. Our reading of the document is at Clearer safeguards, figures that do not reconcile, and a screening method that needs explaining. The conditions now stated are that the Committee be satisfied that the necessary clinical assurance has been received and appropriate arrangements are in place, and, for referrals to restart, that any identified improvements have been addressed. Neither is a criterion anyone outside the Committee can test, and the second cannot be assessed by anyone until the review says what the improvements are.

Why this matters now

As at the Joint Committee’s meeting of 22 September the review the pause defers to had not begun. The terms of reference were said that day to be agreed or in their final stages and due within the week; three days later the position was that the Committee intends to publish them soon, after affected patients have been written to. On 5 October the health board published both a detailed account of how the review will work and the terms of reference themselves — on its own website rather than the Committee’s, and ten days after the week they were promised in. (Updated, 10 October 2026: the Committee published them on its own website the next day, 6 October.)

Existing waits on some of these surgical pathways already run to approximately eight years. Preparation for genital reconstructive surgery includes permanent hair removal at the donor site, which is months of self-funded treatment scheduled around a surgical date. A cancellation with no new date does not move an appointment; it strands people mid-preparation.

Separately, NHS England has advised that New Victoria Hospital will cease providing masculinising gender surgery from November 2026, with limited alternative capacity and further delays anticipated that fall disproportionately on Welsh patients. That is a second pressure on the same cohort, arriving while the first is unresolved.

Where it stands

We are a party to this matter, not a neutral observer. Everything we have published rests on documents the Committee and the health board have themselves published, and on the published recording of the Joint Committee meeting of 22 September.

Our correspondence — we have written ten times to the Committee (one of them a same-day withdrawal of a question), four times to Llais (not counting a short acknowledgement of its reply of 25 September), and made submissions to two Senedd committees, one of which has now been published. Three of our letters are now statutory requests under the Freedom of Information Act, a route we asked for in only one case; whether a request signed with a first name only is valid is an open question, set out on that page. Llais has answered fully, four times, and corrected its own answer without being asked. (Updated 12 October 2026: Llais answered our letter of 5 October on 12 October, and answered our follow-up question the same day. This said three letters to Llais and two full answers.)

Corrected, 10 October 2026: this previously said we had written eight times to the Committee and twice to Llais. The correspondence page lists ten letters to the Committee and three to Llais. Llais’s reply of 25 September, and our short acknowledgement of it, were added to that page later the same day. It also stated the statutory route without the name question.

Others’ actions. A Senedd petition, “Immediately unfreeze gender-affirming surgeries and protect NHS Welsh Gender Service patients”, had more than 17,900 signatures as at 10 October. It passed the 10,000 at which the Petitions Committee considers a debate on 5 September, and no debate has been scheduled. It is not ours. (Added 10 October 2026.)

Commitments made — what the Committee and the health board have promised about the review, the terms of reference and the return of surgery, in their own words, and whether it has been kept. We update it when something is met as promptly as when something is missed.

Why we are involved, and how

Eden Openly publishes evidence reviews and appraisals in trans healthcare and dermatology. The preparation for these procedures is substantially dermatological, and the reasoning the pause rests on is a question of evidence appraisal rather than of gender medicine. We are not in Wales, hold no relationship with the Welsh Gender Service or any body involved, and have no patients affected. Everything we publish rests on documents anyone can open. Our full position on funding and interests is set out in our statement of independence.

We correct ourselves in public. Every correction in this coverage is marked and dated on the page it concerns, and where text has been removed the note says what it said. Most were found by our own checking rather than after being challenged. The most recent, on 10 October, are on this page and are listed on our updates page. (Corrected, 10 October 2026: this previously said every correction is “left visible” on the page. Two passages have been removed, each with a note.)

A commissioner may take an urgent decision on incomplete information. What it cannot then do is offer a reconstruction written afterwards as the reasoning for it.

Corrected, 10 October 2026: this line previously ended “present the reconstruction as assurance”. The papers of 17 September went to the Committee for noting, not for assurance; see the correction on The papers justifying the pause do not hold up.

Eden Openly is an independent clinical health-education publication. It receives no funding from, and has no commercial relationship with, any provider of gender-related healthcare, any pharmaceutical company, or any supplier of NHS digital systems. Figures checked against the NHS Wales Joint Commissioning Committee’s published papers for its meeting of 22 September 2026 and for its Quality, Safety and Outcomes Sub-Committee meeting of 24 August 2026 (added 10 October 2026: the New Victoria Hospital point comes from the August papers), and Cardiff and Vale University Health Board’s published updates. Corrections and queries: [email protected].